What tests and treatment should be ordered for a giant cell arteritis (GCA) workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Giant Cell Arteritis Workup

The diagnostic workup for giant cell arteritis (GCA) should include erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), complete blood count with platelets, and temporal artery biopsy, with immediate initiation of high-dose glucocorticoid therapy if clinical suspicion is high. 1

Clinical Assessment for GCA

When evaluating a patient for possible GCA, focus on these key clinical features with their associated likelihood ratios:

High-Value Clinical Findings

  • Limb claudication (positive LR 6.01) 2
  • Jaw claudication (positive LR 4.90) 2, 1
  • Temporal artery abnormalities:
    • Thickening (positive LR 4.70) 2
    • Loss of pulse (positive LR 3.25) 2
    • Tenderness (positive LR 3.14) 2
  • Age ≥50 years (absence of age >70 years has negative LR 0.48) 2, 1
  • New-onset localized headache 1

Laboratory Testing

Order these tests immediately for suspected GCA:

  1. Erythrocyte sedimentation rate (ESR):

    • ESR >100 mm/h has positive LR 3.11 2
    • Absence of ESR >40 mm/h has negative LR 0.18 (strong evidence against GCA) 2, 1
    • Sensitivity 84-89% 3, 4
  2. C-reactive protein (CRP):

    • Absence of CRP ≥2.5 mg/dL has negative LR 0.38 2, 1
    • Sensitivity 86-100% (higher than ESR) 3, 4
  3. Complete blood count with platelets:

    • Platelet count >400 × 10³/μL has positive LR 3.75 2, 1
    • High specificity (88%) but lower sensitivity (38%) 5

Important caveat: While inflammatory markers are typically elevated in GCA, approximately 4-15% of cases may present with normal ESR, and about 0.8% may have both normal ESR and normal CRP 6, 7, 3. Therefore, normal inflammatory markers do not rule out GCA if clinical suspicion remains high.

Diagnostic Confirmation

Temporal Artery Biopsy

  • Gold standard for diagnosis 1, 6
  • Obtain a long-segment specimen (>1 cm) to reduce false negatives from "skip lesions" 1
  • Should be performed within 2 weeks of starting glucocorticoids 1
  • Initially, perform unilateral biopsy on the symptomatic side 1

Vascular Imaging (if biopsy is negative but suspicion remains high)

  • Vascular ultrasound: Non-invasive, high sensitivity and specificity 1, 6
  • MRI/MRA of cranial arteries 1
  • CT angiography 1
  • FDG-PET/CT in select cases 1

Treatment Initiation

  • Start high-dose glucocorticoids immediately if clinical suspicion is high, even before diagnostic confirmation, due to risk of permanent vision loss 1
  • Prednisone 40-60 mg/day for initial treatment 1
  • IV methylprednisolone 500-1000 mg/day for patients with visual symptoms 1
  • Consider tocilizumab to reduce glucocorticoid requirements and prevent relapses 1

Diagnostic Algorithm

  1. Assess clinical features for likelihood of GCA
  2. Order laboratory tests: ESR, CRP, and CBC with platelets
  3. Initiate glucocorticoids immediately if clinical suspicion is high
  4. Arrange temporal artery biopsy within 2 weeks of starting treatment
  5. If biopsy is negative but suspicion remains high, proceed with vascular imaging
  6. Refer urgently to specialists for patients with visual symptoms or other high-risk features 1

Clinical pearl: The combination of CRP and platelet count can allow for faster initial decision-making without waiting for ESR results, as sequential analysis has shown ESR may not provide additional diagnostic value when the other markers are available 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.